← Today's headlines

2 sources checked · 2 source groups included · 5h ago

Needs Review

Eli Lilly Sues COGIC Leaders Over Alleged $200 Million Drug Rebate Scheme

Pharmaceutical giant Eli Lilly and Company has filed a civil suit alleging four leaders in the Church of God in Christ (COGIC) helped facilitate a fraudulent drug rebate scheme that cost the drug manufacturer more than $200 million. In its 66-page lawsuit, the company says the plot it uncovered was...

1 Left0 Center1 Right
Needs review. This source map is too narrow, too early, or mixed-format to trust yet.

NEEDS REVIEW

As of May 21, 2026 at 11:06 PM, this is how Optics News reads the wording differences in this story.

What happened Eli Lilly Sues COGIC Leaders Over Alleged $200 Million Drug Rebate Scheme.
The headline split One side frames it as "A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says". The other frames it as "Eli Lilly Sues COGIC Leaders Over Alleged $200 Million Drug Rebate Scheme".
Can I trust it? Not yet. Only 2 sources are matched, and the match is still narrow.

Wording differs, but the match is too narrow to read confidently yet.

WHAT EACH SIDE EMPHASIZED

Left / center-leftA Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says

Time · Center-left · News report

CenterNo matching source in this bucket yet.

Optics keeps watching for pickup.

Right / center-rightEli Lilly Sues COGIC Leaders Over Alleged $200 Million Drug Rebate Scheme

Christianity Today · Center-right · News report

SEE THE HEADLINES

CR · Center-rightMostly Factual
Christianity TodayNews report · May 21, 11:06 PM

Eli Lilly Sues COGIC Leaders Over Alleged $200 Million Drug Rebate Scheme

schemesuescogicleadersover

Pharmaceutical giant Eli Lilly and Company has filed a civil suit alleging four leaders in the Church of God in Christ (COGIC) helped facilitate a fraudulent drug rebate scheme that cost th...

Open source
CL · Center-leftHigh
TimeNews report · May 21, 4:34 PM

A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says

next-generationcausesdramaticweightloss

Retatrutide, an experimental injectable drug, targets three hormones related to weight loss.

Open source
DetailsScore hidden · 2 sources · 2 bias buckets
Score hidden until the match is cleanerLow confidence2 sources · 2 bias bucketsDeveloping · 2 sources · 2 bucketsFormats: News report

SOURCE MAP CHANGES

May 21, 4:34 PM: Time joined the source map.

May 21, 11:06 PM: Christianity Today joined the source map.

Now: score hidden until the source match is cleaner. Story health is developing · 2 sources · 2 buckets.